Sonnenfeld on regulation & risk - The Deal Pipeline (SAMPLE CONTENT: NEED AN ID?)
Subscriber Content Preview | Request a free trialSearch  
  Go

Video

Share  |  Reprint

Sonnenfeld on regulation & risk

Published December 9, 2011 at 4:00 AM

Jeffery Sonnenfeld of the Yale School of Management chats with The Deal Pipeline about the most important themes that were discussed during the town hall he led on Dec. 1 at The Deal Economy 2012 event. Among those issues were regulation and uncalibrated risk in the U.S. as they relate to Europe's debt issues. - Sarah Hashim-Waris
Share:

Meet the journalists



Movers & Shakers

Launch Movers and shakers slideshow

Three directors are leaving Valeant Pharmaceuticals International's board, including Warburg Pincus' Fred Hassan, ValueAct's G. Mason Morfit and Persistence Capital's Lloyd M. Segal. For other updates launch today's Movers & shakers slideshow.

Video

Ackman goes raider route in backing Valeant's Allergan bid

The move suggests activism has entered a new phase. But as seen with the Men′s Wearhouse-Jos. A. Bank merger, it′s just another way for dissident investors to push their agendas. More video

Sectors